Thromboelastography: Current Applications, Future Directions  

作　　者：Linda M. Trapani 

机构地区：[1]The Brooklyn Hospital Center, Brooklyn, USA.

出　　处：《Open Journal of Anesthesiology》2013年第1期23-27,共5页麻醉学期刊（英文）

摘　　要：Analyzing coagulability often hinges on patient surveillance using prothrombin time (PT) or international normalized ratio (INR) and activated partial thromboplastin time (aPTT) to monitor the extrinsic and intrinsic coagulation pathways, respectively A more complete assessment, however, can often be obtained using thromboelastography (TEG), a coagulation assay that evaluates the efficiency of clot formation, as well as the viscoelastic properties of the clot. Developed by Dr. Helmut Hartert in 1948 at the UniversityofHeidelberg, it provides information regarding hemostasis as a dynamic process [1,2]. Here, the TEG technique will be described, as well as its current applications and future directions for its use.Analyzing coagulability often hinges on patient surveillance using prothrombin time (PT) or international normalized ratio (INR) and activated partial thromboplastin time (aPTT) to monitor the extrinsic and intrinsic coagulation pathways, respectively A more complete assessment, however, can often be obtained using thromboelastography (TEG), a coagulation assay that evaluates the efficiency of clot formation, as well as the viscoelastic properties of the clot. Developed by Dr. Helmut Hartert in 1948 at the UniversityofHeidelberg, it provides information regarding hemostasis as a dynamic process [1,2]. Here, the TEG technique will be described, as well as its current applications and future directions for its use.

关 键 词：THROMBOELASTOGRAPHY Rotational THROMBOELASTOMETRY Cardiopulmonary Bypass Coagulation Index Adenosine DIPHOSPHATE PROTHROMBIN TIME Partial THROMBOPLASTIN TIME International Normalized Ratio 

分 类 号：R73[医药卫生—肿瘤]